Intermec (IN) – Corporate News
-
InMed Pharmaceuticals Inc. (INM) Reports Submission of Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa
-
InMed Pharmaceuticals (INM) Announces Voluntary Delisting from TSX
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to IN Stock Lookup